BioLife Solutions Stock Income Statements

BioLife Solutions Quarterly Income Statements Chart

Quarterly

Annual

Operating Profit

Net Income

BioLife Solutions Quarterly Income Statements Table

Quarterly

Annual

Unit: USD	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-09-30	2008-06-30	2008-03-31

product revenue	22,299,000	11,404,000	23,457,000	21,310,000	24,803,000	26,175,000	26,891,000	33,037,000	31,593,000	37,773,000	33,668,000	34,170,000	30,388,000	31,468,000	29,201,000	27,468,000	13,776,000	12,520,000	10,804,000	9,489,000	11,727,000				5,770,000				3,814,882				2,366,201				1,852,017				1,500,722
service revenue	60,000	-14,013,000	4,660,000	4,427,000	5,088,000	4,508,000	4,378,000	4,195,000	4,471,000	4,191,000	4,330,000	3,698,000	3,090,000	3,400,000	2,250,000	1,963,000	2,204,000
rental revenue	1,582,000	-815,000	2,454,000	2,591,000	1,836,000	2,050,000	2,059,000	2,276,000	1,639,000	2,295,000	2,749,000	2,665,000	2,742,000	2,437,000	2,349,000	1,773,000	867,000	454,000	475,000	431,000	435,000
total product, rental, and service revenue	23,941,000	21,419,500	30,571,000	28,328,000	31,727,000	27,634,500	33,328,000	39,508,000	37,703,000	29,375,000	40,747,000	40,533,000	36,220,000	20,462,750	33,800,000	31,204,000	16,847,000
costs and operating expenses:
cost of product revenue	7,109,000	-661,000	8,765,000	8,614,000	14,384,000	18,729,000	16,665,000	21,961,000	18,397,000	25,142,000	21,876,000	21,561,000	20,384,000	26,396,000	21,672,000	15,986,000	5,622,000
cost of service revenue	10,000	-10,195,000	3,401,000	3,327,000	3,519,000	3,713,000	3,945,000	4,038,000	3,891,000	3,550,000	3,253,000	2,968,000	2,145,000	833,000	1,768,000	1,427,000	1,353,000
cost of rental revenue	1,036,000	-839,000	2,110,000	1,494,000	1,263,000	1,041,000	1,069,000	1,697,000	1,376,000	1,596,000	1,880,000	1,665,000	1,917,000	3,911,000	1,424,000	1,141,000	575,000
general and administrative	11,501,000	6,588,000	11,351,000	10,894,000	12,934,000	12,968,000	12,513,000	15,402,000	14,842,000	13,542,000	11,581,000	11,351,000	11,196,000	10,390,000	10,081,000	7,146,000	4,830,000	4,691,000	3,503,000	3,278,000	3,135,000	6,635,000	2,258,000	2,118,000	2,204,000		1,454,573	1,390,524	1,353,377	1,224,018	1,118,251	1,077,067	1,103,143	954,902	1,039,223	1,262,818	1,335,292	1,354,123	1,263,272	1,030,701	1,220,705	1,011,316	969,799	863,743	862,591	630,342	601,617	624,427	709,965	487,733	475,006	479,113	473,085	500,424	401,423	454,375	1,179,343	321,337	386,626	442,574	1,158,282	345,270	379,172	456,075	481,771	465,502	512,458
sales and marketing	2,597,000	-791,000	3,543,000	3,502,000	5,070,000	4,538,000	7,256,000	6,318,000	6,471,000	5,987,000	5,277,000	5,415,000	4,891,000	4,778,000	4,065,000	3,142,000	2,021,000	1,883,000	1,588,000	1,366,000	1,576,000	3,442,000	1,259,000	928,000	848,000		725,201	641,168	611,502	539,339	488,688	546,455	511,944	610,406	816,025	849,193	733,913	763,953	677,033	642,490	500,255	298,263	270,616	241,400	215,851	208,080	214,762	202,758	239,428	145,735	160,658	73,381	69,197	55,443	59,132	83,308	339,653	91,354	117,017	123,028	426,558	132,163	211,038	123,581	80,400	76,415	96,086
research and development	2,204,000	1,085,000	2,050,000	2,382,000	3,534,000	4,399,000	5,402,000	4,840,000	4,152,000	4,164,000	3,425,000	3,428,000	3,781,000	3,571,000	3,219,000	3,045,000	1,987,000	1,855,000	1,725,000	1,477,000	1,663,000	1,859,000	1,309,000	739,000	372,000		312,000	324,612	346,454	294,964	293,093	318,607	286,751	428,321	496,874	599,031	504,239	425,781	329,527	301,334	322,165	153,328	192,778	167,287	126,412	160,528	94,908	105,968	109,801	110,689	126,627	116,521	125,368	98,903	133,390	158,793	220,547	98,350	81,502	66,932	341,198	73,267	141,946	133,624	94,133	103,377	111,302
intangible asset amortization	702,000	3,000	910,000	910,000	914,000	915,000	1,356,000	1,450,000	1,459,000	1,461,000	2,513,000	2,863,000	2,863,000	2,862,000	2,525,000	1,882,000	933,000
total operating expenses	25,159,000	-4,810,000	32,130,000	31,123,000	41,855,000	45,888,000	62,111,000	54,788,000	51,308,000	94,500,000	52,152,000	116,795,000	43,853,000	54,550,000	44,959,000	35,759,000	17,828,000	19,469,000	12,525,000	9,876,000	11,792,000	22,474,000	5,117,000	3,824,000	3,632,000		2,491,774	2,356,304	2,311,333	2,058,321	1,900,032	1,942,129	1,901,838	1,993,629	2,352,122	2,711,042	2,573,444	2,543,857	2,269,832	1,974,525	2,043,125	1,462,907	1,433,193	1,272,430	1,204,854	998,950	911,287	933,153	1,059,194	744,157	762,291	669,015	667,650	654,770	593,945	696,476	1,739,543	511,041	585,145	632,534	2,311,243	550,700	950,410	880,231	762,598	645,294	719,846
operating income	-1,218,000	1,386,000	-1,559,000	-2,795,000	-10,128,000	-13,155,000	-28,783,000	-15,280,000	-13,605,000	-50,241,000	-11,405,000	-76,262,000	-7,633,000	-17,245,000	-11,159,000	-4,555,000	-981,000	-4,743,000	-1,246,000	44,000	370,000	377,000	-597,000	919,000	491,000		1,194,998	1,284,771	139,720	-218,260	-32,345	-341,203	-464,039	-627,358	-1,137,860	-1,593,889	-1,492,432	-1,404,302	-1,296,448	-1,155,877	-1,160,502	-874,513	-887,873	-369,041	-284,751	-110,093	-82,844	192,331	-307,636	-148,708	-306,630	-179,264	-210,586	-284,808	-260,012	-454,277	-1,108,000	-286,196	-391,527	-393,814	-1,854,480	-432,885	-892,733	-733,396	-588,498	-594,692	-560,614
yoy	-87.97%	-110.54%	-94.58%	-81.71%	-25.56%	-73.82%	152.37%	-79.96%	78.24%	191.34%	2.20%	1574.25%	678.08%	263.59%	795.59%	-10452.27%	-365.14%	-1358.09%	108.71%	-95.21%	-24.64%		-149.96%	-28.47%	251.42%		-3794.54%	-476.54%	-130.11%	-65.21%	-97.16%	-78.59%	-68.91%	-55.33%	-12.23%	37.89%	28.60%	60.58%	46.02%	213.21%	307.55%	694.34%	971.74%	-291.88%	-7.44%	-25.97%	-72.98%	-207.29%	46.09%	-47.79%	17.93%	-60.54%	-80.99%	-0.48%	-33.59%	15.35%	-40.25%	-33.89%	-56.14%	-46.30%	215.12%	-27.21%	59.24%
qoq	-187.88%	-188.90%	-44.22%	-72.40%	-23.01%	-54.30%	88.37%	12.31%	-72.92%	340.52%	-85.04%	899.11%	-55.74%	54.54%	144.98%	364.32%	-79.32%	280.66%	-2931.82%	-88.11%	-1.86%	-163.15%	-164.96%	87.17%			-6.99%	819.53%	-164.02%	574.79%	-90.52%	-26.47%	-26.03%	-44.87%	-28.61%	6.80%	6.28%	8.32%	12.16%	-0.40%	32.70%	-1.50%	140.59%	29.60%	158.65%	32.89%	-143.07%	-162.52%	106.87%	-51.50%	71.05%	-14.87%	-26.06%	9.54%	-42.76%	-59.00%	287.15%	-26.90%	-0.58%	-78.76%	328.40%	-51.51%	21.73%	24.62%	-1.04%	6.08%
operating margin %																						22.83%	-9.04%
other income:
interest income	681,000									-506,000	10,000			-101,000	-194,000	-121,000	-16,000	-5,000	16,000	18,000	29,000	396,000	110,000	137,000	171,000		79,773	32,537	8,418	123	103	76	48	26	30	445	1,919	3,305	4,729	5,482	8,237	7,658	4,517										3	20	2	21	166	27	76	36	901	168	195	681	1,052	485	4,255
other income	103,000	80,000	95,000	84,000	245,000	237,000	242,000	390,000	394,000	434,000	142,000	-22,000	131,000	296,000	-7,000			-2,250	-5,000		-4,000																														5,981	88,272														10,495
total other income	784,000	157,000	-172,000	-4,351,000	38,000	-270,000	-234,000	5,086,000	-17,000	-72,000	849,000	-31,000	-32,000	195,000	6,250,000	-121,000	-137,000	-649,000	113,000	-16,424,000	21,938,000													-2,937,814	-128,115	-125,823		3,305	4,729	5,482	8,237	12,058	4,517	-190,330	-199,817	-199,817	-199,662	-199,507	-203,952	-203,520	-192,263	-117,613	-200,584	-193,860	-176,667	-175,845	-438,898	-150,536	-145,617	-137,962	-351,251	-129,736	-120,195	-106,172	-74,327	-67,802	-84,913
income before income tax expense	-434,000			-7,146,000	-10,090,000
income tax expense	-14,000	-122,000			-131,000
net income from continuing operations	-448,000	-3,265,250	-1,703,000	-7,146,000
discontinued operations:
income from discontinued operations before income tax expense
income from discontinued operations		10,775,000		-13,573,000
net income	-448,000	12,459,000	-1,703,000	-20,719,000	-10,221,000	-13,382,000	-29,132,000	-10,199,000	-13,714,000	-50,228,000	-9,957,000	-72,554,000	-7,066,000	-14,472,000	79,000	7,876,000	-1,118,000	-2,128,000	-1,133,000	-16,380,000	22,308,000	-10,973,000	9,316,000	838,000	427,000				3,482	-557,886	-318,718	-768,212	-870,290	-3,565,172	-1,265,975	-1,719,712	-1,490,513				-1,152,265	-862,455	-883,356	-559,371	-484,568	-309,910	-282,506	-7,176	-511,588	-352,228	-498,893	-296,877	-411,170	-478,668	-436,679	-630,122	-1,546,898	-436,732	-537,144	-531,776	-2,205,731	-562,621	-1,012,928	-839,568	-662,825	-662,494	-645,527
yoy	-95.62%	-193.10%	-94.15%	103.15%	-25.47%	-73.36%	192.58%	-85.94%	94.08%	247.07%	-12703.80%	-1021.20%	532.02%	580.08%	-106.97%	-148.08%	-105.01%	-80.61%	-112.16%	-2054.65%	5124.36%				12163.07%				-100.40%	-84.35%	-74.82%	-55.33%	-41.61%				29.36%				137.79%	178.29%	212.69%	7695.03%	-5.28%	-12.01%	-43.37%	-97.58%	24.42%	-26.41%	14.25%	-52.89%	-73.42%	9.60%	-18.70%	18.49%	-29.87%	-22.38%	-46.97%	-36.66%	232.78%	-15.08%	56.91%
qoq	-103.60%	-831.59%	-91.78%	102.71%	-23.62%	-54.06%	185.64%	-25.63%	-72.70%	404.45%	-86.28%	926.80%	-51.17%	-18418.99%	-99.00%	-804.47%	-47.46%	87.82%	-93.08%	-173.43%	-303.30%	-217.79%	1011.69%	96.25%					-100.62%	75.04%	-58.51%	-11.73%	-75.59%	181.61%	-26.38%	15.38%					33.60%	-2.37%	57.92%	15.44%	56.36%	9.70%	3836.82%	-98.60%	45.24%	-29.40%	68.05%	-27.80%	-14.10%	9.62%	-30.70%	-59.27%	254.20%	-18.69%	1.01%	-75.89%	292.05%	-44.46%	20.65%	26.67%	0.05%	2.63%
net income margin %																						-664.63%	141.07%
income from continuing operations, attributable to common shareholders:
basic and diluted	-448,000	-3,265,250	-1,703,000	-7,146,000
income from discontinued operations, attributable to common shareholders:
basic and diluted		-4,895,500		-13,573,000
loss per share from continuing operations, attributable to common shareholders:
basic and diluted	-0.01	-0.07	-0.04	-0.16
loss per share from discontinued operations, attributable to common shareholders:
net income attributable to common shareholders:
basic and diluted	-448				-10,221,000	-13,382,000	-29,132,000	-10,199,000	-13,714,000				-7,066,000
net income per share
basic and diluted	-0.01				-0.22	-0.3	-0.67	-0.23	-0.32				-0.17
weighted-average shares used for eps calculation
basic and diluted	47,134,720				45,432,426	43,719,185	43,570,438	43,441,219	43,027,612	42,481,027,000			42,014,055	38,503,944,000			33,236,818	27,306,258				19,460,299
asset impairment charges							15,485,000
change in fair value of contingent consideration						-415,000	-1,580,000	-918,000	720,000	-1,406,000	2,346,000	-2,361,000	-3,335,000	1,789,000	-140,000	1,718,000	-491,000	3,103,000	-2,000	-1,463,000	-63,000
change in fair value of equity investments		-1,018,500		-4,074,000
gain on settlement of global cooling escrow								5,115,000
interest expense		77,000	-267,000	-361,000	-207,000	-507,000	-476,000	-419,000	-411,000			-9,000	-163,000					-1,000	-3,000		-1,000	-4,000	-1,000	-1,000	-3,000		-1,313	-1,332	-900	-1,077	-1,077													-177,308	-185,555	-185,554	-185,555	-185,555	-185,555	-185,554	-183,543	-178,777	-173,528	-171,677	-165,239	-160,542	-437,438	-150,563	-145,693	-136,372	-359,721	-128,292	-118,267	-106,853	-75,379	-78,782	-45,418
income before income tax benefit		-3,242,000	-1,731,000			-13,425,000	-29,017,000	-10,194,000	-13,622,000	-50,313,000	-10,556,000	-76,293,000	-7,665,000	-17,050,000	-4,909,000	-4,676,000
income tax benefit		131,000	28,000			43,000	-115,000	-5,000	-92,000	85,000	599,000	3,739,000	599,000	2,578,000	4,988,000	12,552,000
acquisition costs					237,000						1,000	5,000	11,000	20,000	345,000	272,000	998,000	251,000	179,000	13,000	225,000	649,000	291,000	39,000	208,000
change in fair value of investments											697,000							209,000	1,110,000
intangible asset impairment charges										40,464,000		69,900,000
change in fair value of warrant liability																	-121,000	-866,000	-1,005,000	-16,442,000	21,914,000
gain on acquisition of sexton biotechnologies, inc.															6,451,000
net income attributable to common shareholders:
basic										-50,228,000	-9,957,000	-72,554,000		-14,256,000	77,000	7,661,000	-1,118,000	-1,872,000	-1,133,000	-16,380,000	18,364,000
diluted										-50,228,000	-9,957,000	-72,554,000		-14,263,000	77,000	7,668,000	-1,118,000	-1,233,000	-1,133,000	-16,380,000	-174,000
net income per share
basic										-0.528	-0.23	-1.71
diluted										-0.528	-0.23	-1.71
weighted-average shares used for eps calculation
basic		46,067,073									42,647,967	42,460,189			40,911,801	38,072,712,000			31,639,420	23,292,635	21,010,817
diluted		46,067,073									42,647,967	42,460,189			43,296,470	40,390,098,000			31,639,420	23,292,635	21,010,817
earnings per share attributable to common shareholders:
basic														0.045	0		-0.03	-0.08	-0.04	-0.7	0.87
diluted														0.043	0		-0.03	-0.04	-0.04	-0.7	-0.01
net income attributable to shareholders
basic										-50,228,000	-9,957,000	-72,554,000		-14,256,000	77,000	7,661,000	-1,118,000	-1,872,000	-1,133,000	-16,380,000	18,364,000
diluted										-50,228,000	-9,957,000	-72,554,000		-14,263,000	77,000	7,668,000	-1,118,000	-1,233,000	-1,133,000	-16,380,000	-174,000
earnings attributable to common shareholders
basic																200
diluted																190
net income before benefit from income taxes																	-1,118,000	-5,392,000	-1,133,000	-16,380,000	22,308,000						1,230,769	1,139,178
net income attributable to stockholders
basic										-50,228,000	-9,957,000	-72,554,000		-14,256,000	77,000	7,661,000	-1,118,000	-1,872,000	-1,133,000	-16,380,000	18,364,000
diluted										-50,228,000	-9,957,000	-72,554,000		-14,263,000	77,000	7,668,000	-1,118,000	-1,233,000	-1,133,000	-16,380,000	-174,000
earnings per share attributable to common stockholders:
basic														0.045	0		-0.03	-0.08	-0.04	-0.7	0.87
diluted														0.043	0		-0.03	-0.04	-0.04	-0.7	-0.01
total product and rental revenue																		8,340,250	11,279,000	9,920,000	12,162,000
operating expenses
cost of product and rental revenue																		3,473,250	4,826,000	4,499,000	4,568,000
intangible assets amortization																		525,000	706,000	706,000	688,000
income from equity method investment in savsu
gain on acquisition of savsu																							10,108,000
income tax
net income attributable to common stockholders:
basic										-50,228,000	-9,957,000	-72,554,000		-14,256,000	77,000	7,661,000	-1,118,000	-1,872,000	-1,133,000	-16,380,000	18,364,000
diluted										-50,228,000	-9,957,000	-72,554,000		-14,263,000	77,000	7,668,000	-1,118,000	-1,233,000	-1,133,000	-16,380,000	-174,000
earnings per share attributable to common stockholders
basic														0.045	0		-0.03	-0.08	-0.04	-0.7	0.87
diluted														0.043	0		-0.03	-0.04	-0.04	-0.7	-0.01
revenue																						1,651,000	6,604,000
yoy
qoq																						-75.00%
cost of revenue																						521,000	2,084,000
gross profit																						1,130,000	4,520,000	4,743,000	4,123,000		3,686,772	3,641,075	2,451,053	1,840,061	1,867,687	1,600,926	1,437,799	1,366,271	1,214,262	1,117,153	1,081,012	1,139,555	973,384	818,648	882,623	588,394	545,320	903,389	920,103	888,857	828,443	1,125,484	751,558	595,449	455,661	489,751	457,064	369,962	333,933	242,199	631,543	224,845	193,618	238,720	456,763	117,815	57,677	146,835
yoy																							22.60%	30.26%	68.21%		97.40%	127.44%	70.47%	34.68%	53.81%	43.30%	33.00%	19.90%	24.75%	36.46%	22.48%	93.67%	78.50%	-9.38%	-4.07%	-33.80%	-34.18%	-19.73%	22.43%	49.28%	81.81%	129.81%	64.43%	60.95%	36.45%	102.21%	-27.63%	64.54%	72.47%	1.46%	38.26%	90.85%	235.69%	62.58%
qoq																						-75.00%	-4.70%	15.04%			1.26%	48.55%	33.20%	-1.48%	16.66%	11.35%	5.24%	12.52%	8.69%	3.34%	-5.14%	17.07%	18.90%	-7.25%	50.01%	7.90%	-39.64%	-1.82%	3.52%	7.29%	-26.39%	49.75%	26.22%	30.68%	-6.96%	7.15%	23.54%	10.79%	37.88%	-61.65%	180.88%	16.13%	-18.89%	-47.74%	287.70%	104.27%	-60.72%
gross margin %																						68.44%	68.44%
other income (expenses)
loss on disposal of assets																						-3,250	-13,000
income from equity-method investment in savsu																						-448,000	-291,000	-217,000	-232,000		-42,689	-176,798	-143,756	-297,672	-217,735	-260,105	-229,368
total other income (expenses)																						2,478,250	9,913,000	-81,000	-64,000		35,771	-145,593	-136,238	-279,908.25	-286,373	-427,009	-406,251
income before benefit from income taxes																						2,329,000	9,316,000	838,000
income taxes
less: preferred stock dividends																											-79,675	-93,258	-106,250	-106,250	-106,250
net income attributable to common stockholders																						-10,973,000	9,316,000	838,000	427,000		1,151,094	1,045,920	-102,768	-664,136	-424,968
basic net income per common share																						117.5	470	40	20		0.07	0.07
diluted net income per common share																						92.5	370	30	20		0.05	0.05
basic shares used to compute earnings per share																						4,933,841	19,735,364	18,819,459				15,180,169
diluted shares used to compute earnings per share																						6,335,778	25,343,112	24,539,299				20,374,358
product sales																								6,701,000			5,293,075	5,177,854		3,134,444	2,963,411	2,557,765		2,249,790	2,135,197	1,989,988		1,819,503	1,631,926	1,496,759		1,243,372	1,211,900	2,065,030	2,288,880	2,170,491	2,330,018	1,550,845	2,043,220	1,676,480	1,092,409	830,880	804,564	710,518	617,848	605,799	1,541,673	519,892	462,771	507,909	1,115,074	441,526	271,528	367,945	296,620	266,713	306,384
cost of product sales																								1,958,000	1,647,000		1,606,303	1,536,779	1,363,829	1,294,383	1,095,724	956,839	928,402	883,519	920,935	872,835	771,005	679,948	658,542	678,111	618,099	654,978	666,580	1,161,641	1,368,777	1,281,634	1,501,575	1,034,528	1,296,662	1,086,031	641,748	346,129	352,500	345,556	288,915	368,600	925,130	300,047	274,153	274,189	677,477	329,545	218,851	230,277	133,770	227,361	158,402
weighted-average shares outstanding used to compute basic earnings per share																									18,648,397	16,256,465	17,273,412
weighted-average shares outstanding used to compute diluted earnings per share																									24,358,475	21,627,278	23,656,633
write-off of deferred financing costs																														-16,916	-67,664			-21,684		-86,736
amortization of debt discount																																-62,398	-93,598	-93,597	-93,598	-31,199
net income after benefit from income taxes																											1,230,769	1,139,178
basic and diluted net income per common share																													-0.01													-0.07	-0.07	-0.1	-0.21	0	0	0		-0.01	-0.01	0	-0.01	-0.01	-0.01	-0.01	-0.003	-0.01	-0.01	-0.01	-0.003	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01
basic and diluted weighted-average common shares used to calculate net income per common share																													14,098,610	13,263,881	13,238,248	13,100,820	12,964,639	12,642,996	12,699,419	12,568,041	12,457,858	12,177,396			12,100,588	12,042,739	12,010,361	5,568,802	5,007,999	70,106,312	70,035,710	69,873,598	69,679,854	69,679,854	69,679,854	69,679,854	69,679,854	69,679,854	69,679,854	69,679,854		69,679,854	69,679,854	69,679,854		69,639,854	69,639,854	69,639,854	69,639,854	69,639,854	69,606,520
loss on disposal of property and equipment																																			-1,213																	-63	283	-1,896						-1,626	-403	-1,612	-2,123
net income attributable to non-controlling interest																																		241,638	296,974	363,629	263,685				120,783
net income attributable to biolife solutions, inc.																														-557,886	-318,718	-768,212	-870,290	-3,323,534	-969,001	-1,356,083	-1,226,828				-1,031,482
basic and diluted net income per common share attributable to biolife solutions, inc.																														-0.05	-0.03	-0.06	-0.07	-0.26	-0.08	-0.11	-0.1				-0.09
interest expense, related party																																-104,582	-83,333	-58,333	-33,334	-8,333
gain on disposal of property and equipment																																																		431
amortization of deferred financing costs																																												-13,022	-14,262	-14,263	-14,107	-13,952	-18,397	-18,397	-14,701	-27,045	-27,342	-20,307	-11,430	-15,324											-43,750
licensing revenue																																																609,167	5,000	5,000	5,000	5,000	5,000	5,000	5,000	5,000	15,000	5,000	5,000	5,000	19,166	5,834	5,000	9,167	11,250	11,250	11,250
total revenue																																										1,243,372	1,211,900	2,065,030	2,288,880	2,170,491	2,330,018	2,160,012	2,048,220	1,681,480	1,097,409	835,880	809,564	715,518	622,848	610,799	1,556,673	524,892	467,771	512,909	1,134,240	447,360	276,528	377,112	307,870	277,963	317,634
gain on sale of property and equipment																																										4,400
loss on sale of assets
manufacturing start-up costs																																																															218,254	166,951	106,294
gross margin																																																																	174,100	50,602	159,232

We provide you with 20 years income statements for BioLife Solutions stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of BioLife Solutions stock. Explore the full financial landscape of BioLife Solutions stock with our expertly curated income statements.

The information provided in this report about BioLife Solutions stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.